During the past decade, Matrix Clinical Research conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 1 clinical trials were completed, i.e. on average, 9.1% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Matrix Clinical Research" #1 sponsor was "Celgene" with 3 trials, followed by "Pfizer" with 3 trials sponsored, "BioNTech SE" with 2 trials sponsored, "Bavarian Nordic" with 1 trials sponsored and "Evofem Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Matrix Clinical Research" #1 collaborator was "Pfizer" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Matrix Clinical Research" are "Crohn Disease" (3 trials), "COVID-19" (2 trials), "Respiratory Tract Infection" (2 trials), "Chlamydia" (1 trials) and "Gonorrhea" (1 trials). Many other conditions were trialed in "Matrix Clinical Research" in a lesser frequency.

Most popular intervention types in "Matrix Clinical Research" are "Biological" (5 trials), "Drug" (5 trials), "Other" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Ozanimod" (3 trials), "BNT162b2" (1 trials), "BNT162b2 20mcg" (1 trials) and "BNT162b2 30mcg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Matrix Clinical Research" are 7 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Matrix Clinical Research". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Matrix Clinical Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Matrix Clinical Research, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".